Fresenius Medical Care Affirms FY2026 Sales Guidance of $23.764B vs $22.870B Est

Benzinga Newsdesk www.benzinga.com Positive 49.0%

Neg 0% Neu 0% Pos 49%

Fresenius Medical Care (NYSE:FMS) affirms FY2026 sales outlook from $23.764 billion to $23.764 billion vs $22.870 billion estimate.